These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38025913)

  • 1. Immunization of mice with chimeric protein-loaded aluminum hydroxide and selenium nanoparticles induces reduction of
    Goudarzi T; Abkar M; Zamanzadeh Z; Fasihi-Ramandi M
    Clin Exp Vaccine Res; 2023 Oct; 12(4):304-312. PubMed ID: 38025913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
    Abkar M; Alamian S; Sattarahmady N
    Immunol Lett; 2019 Mar; 207():28-35. PubMed ID: 30707922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization of mice with Omp31-loaded
    Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
    Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal and intraperitoneal immunization against
    Sharif F; Nazari R; Fasihi-Ramandi M; Taheri RA; Zargar M
    Clin Exp Vaccine Res; 2024 Jul; 13(3):232-241. PubMed ID: 39144123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Different aluminum adjuvants significantly enhances the effect of immunization on Brucella Omp31].
    Qing R; Xiang Q; Liu Z; Xiao F; Yang F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):123-128. PubMed ID: 29673454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of glycine nanoparticles containing a chimeric antigen as
    Karevan G; Ahmadi K; Taheri RA; Fasihi-Ramandi M
    Clin Exp Vaccine Res; 2021 Jan; 10(1):35-43. PubMed ID: 33628752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G; Konduru B; Murali HS; Batra HV
    Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of BALB/c mice against pathogenic
    Alizadeh H; Dezfulian M; Rahnema M; Fallah J; Esmaeili D
    Iran J Basic Med Sci; 2019 Nov; 22(11):1302-1307. PubMed ID: 32128095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Immunization of BALB/c Mice against Pathogenic Brucella melitensis and
    Harzandi N; Aghababa H; Khoramabadi N; Tabaraie T
    Iran J Biotechnol; 2021 Jan; 19(1):e2618. PubMed ID: 34179193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
    J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection.
    Naghavi M; Sekhavati MH; Tahmoorespur M; Nassiri MR
    Arch Razi Inst; 2018 Sep; 73(3):199-206. PubMed ID: 30280839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.
    Shirdast H; Ebrahimzadeh F; Taromchi AH; Mortazavi Y; Esmaeilzadeh A; Sekhavati MH; Nedaei K; Mirabzadeh E
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):80-89. PubMed ID: 32661939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax.
    Gogoi H; Mani R; Aggarwal S; Malik A; Munde M; Bhatnagar R
    Int J Nanomedicine; 2020; 15():239-252. PubMed ID: 32021177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.